Fri, November 17, 2017
Thu, November 16, 2017
Wed, November 15, 2017
Tue, November 14, 2017
Mon, November 13, 2017
Fri, November 10, 2017
Thu, November 9, 2017
Wed, November 8, 2017
Tue, November 7, 2017
Mon, November 6, 2017
Fri, November 3, 2017

Andrew Schenker Maintained (THC) at Hold with Decreased Target to $14 on, Nov 9th, 2017


//stocks-investing.news-articles.net/content/201 .. with-decreased-target-to-14-on-nov-9th-2017.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Andrew Schenker of Morgan Stanley, Maintained "Tenet Healthcare Corporation" (THC) at Hold with Decreased Target from $15 to $14 on, Nov 9th, 2017.

Andrew has made no other calls on THC in the last 4 months.



There are 4 other peers that have a rating on THC. Out of the 4 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Credit Suisse" Initiated at Hold and Held Target at $15 on, Thursday, November 2nd, 2017


These are the ratings of the 3 analyists that currently disagree with Andrew


  • Brian Tanquilut of "Jefferies" Maintained at Strong Buy with Decreased Target to $20 on, Monday, October 30th, 2017
  • Ana Gupte of "Leerink Swann" Maintained at Buy with Increased Target to $30 on, Monday, August 21st, 2017
  • Christopher Rigg of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $24 on, Thursday, August 10th, 2017

Publication Contributing Sources